Cargando…
Targeting PCSK9 in Liver Cancer Cells Triggers Metabolic Exhaustion and Cell Death by Ferroptosis
Deregulated lipid metabolism is a common feature of liver cancers needed to sustain tumor cell growth and survival. We aim at taking advantage of this vulnerability and rewiring the oncogenic metabolic hub by targeting the key metabolic player pro-protein convertase subtilisin/kexin type 9 (PCSK9)....
Autores principales: | Alannan, Malak, Fatrouni, Hala, Trézéguet, Véronique, Dittrich-Domergue, Franziska, Moreau, Patrick, Siegfried, Géraldine, Liet, Benjamin, Khatib, Abdel-Majid, Grosset, Christophe F., Badran, Bassam, Fayyad-Kazan, Hussein, Merched, Aksam J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818499/ https://www.ncbi.nlm.nih.gov/pubmed/36611859 http://dx.doi.org/10.3390/cells12010062 |
Ejemplares similares
-
Rewiring Lipid Metabolism by Targeting PCSK9 and HMGCR to Treat Liver Cancer
por: Alannan, Malak, et al.
Publicado: (2022) -
Immuno-Metabolic Modulation of Liver Oncogenesis by the Tryptophan Metabolism
por: Trézéguet, Véronique, et al.
Publicado: (2021) -
PCSK9 in Liver Cancers at the Crossroads between Lipid Metabolism and Immunity
por: Alannan, Malak, et al.
Publicado: (2022) -
High-throughput synthetic rescue for exhaustive characterization of suppressor mutations in human genes
por: Kobaisi, Farah, et al.
Publicado: (2020) -
Study of the microRNA expression profile of foreskin derived mesenchymal stromal cells following inflammation priming
por: Fayyad-Kazan, Hussein, et al.
Publicado: (2017)